News & Analysis as of

Weight-Loss Products › FDA Warning Letters

McDermott Will & Schulte

FDA puts compounded weight loss drug advertising squarely in its crosshairs

McDermott Will & Schulte on

The US Food and Drug Administration (FDA) recently issued warning letters to more than 40 compounding pharmacies, demanding that they cease certain advertising practices for a variety of compounded drug products, including...more

1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide